scorecardresearch
Thursday, August 14, 2025
TopicPharmaceutical companies

Topic: Pharmaceutical companies

Indian drugmaker Lupin voluntarily recalls metformin variant, a diabetes drug, in US

India has said it is monitoring the US FDA updates, which said an extended-release variant of the drug had higher levels of a cancer-causing substance.

AstraZeneca-Gilead deal might not actually happen, say analysts

Political opposition from both Britain and America could derail any attempt at a deal, especially given the backdrop of the Covid-19 outbreak.

Big pharma is looking beyond coronavirus with AstraZeneca eyeing merger with Gilead

The suggestion of a blockbuster merger between the two drugmakers is a sign that the industry is getting back to something resembling business as usual.

Don’t distract doctors with online promotion of brands amid Covid: Modi govt to pharma firms

Order does not clarify what kind of promotions should not be done. Pharma lobbies said they would reach out to govt for clarification.

26 pharma firm employees test positive for Covid-19 in Ahmedabad

95 other employees have been put under home-quarantine, and the company's manufacturing unit and all of Dholka town have been sanitised.

Modi govt halts plan to stop medicine export as firms in coronavirus-hit China resume work

Govt panel formed to tackle ‘drug security concerns’ has decided to monitor situation after Indian embassy in China says several drugmakers there have resumed operations.

Pharma group denies PM Modi had warned companies against unethical marketing

ThePrint had reported that PM Modi told pharma companies to stop bribing doctors. IPA secy general had said he didn’t have any information about such a meeting.

Leave phones outside doctor’s chamber: IMA branch after PM’s bribe warning to pharma firms

Local chapter of IMA in Rajasthan’s Bhilwara has issued certain guidelines for doctors during their interactions with medical representatives.

Govt to begin hunt for a commercially viable new drug molecule made in India

In a first, the Modi government plans to create a separate department for R&D with a focus on discovering new drug molecules.

Modi govt allows 15-20% price hike in medicines that have ‘innovations’

Govt to allow pharma firms to increase price of drugs that are re-launched with “innovations” such as reduced side effects, or user-friendly administration techniques like skin patches.

On Camera

Asim Munir wants to be guardian of the Middle East. He’s fated to fail at home

Countering insurgency needs the Pakistan Army to demonstrate a political will that ties leaders at the centre with those in the borderlands. But it may not have the imagination.

Slashing GST on waste can unlock Rs 1.8 lakh crore, high tax hurting circular economy goals—CSE

Centre for Science and Environment in new report makes case for rationalising GST on waste material, saying most informal operators can’t afford high tax & it also hinders recycling.

India, US troops to undertake joint military exercise next month, first after Op Sindoor

21st edition of annual joint military exercise will be held from 1 to 16 September, aimed at sharing military tech, operational best practices & disaster relief coordination methods.

Modi’s ready to risk it all for farmers. Farm reform can answer Trump with new Green Revolution

Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.